Advertisement
Advertisement
U.S. Markets open in 6 hrs 59 mins
Advertisement
Advertisement
Advertisement
Advertisement

InterCure Ltd. (INCR.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA (0.01 ILS)
Add to watchlist
1,618.00+1.00 (+0.06%)
At close: 05:24PM IDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1,617.00
Open1,568.00
Bid1,565.00 x 7471200
Ask1,570.00 x 1676700
Day's Range1,568.00 - 1,641.00
52 Week Range1,488.00 - 2,635.00
Volume90,979
Avg. Volume63,379
Market Cap72.8B
Beta (5Y Monthly)-0.40
PE Ratio (TTM)N/A
EPS (TTM)-1.47
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est39.53
  • GlobeNewswire

    Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

    HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on Thursday, September 15, 2022, in Bnei Brak, Israel (the “Meeting”). At the Meeting, all of the proposals set forth in the Company’s management information circular dated August 10, 2022 (the “Circular”) were approved by the required majority of the shareholders. Each of the four nominees listed in the man

  • GlobeNewswire

    InterCure Reports Record Breaking Second Quarter Financial Results

    Rapid Revenue and EBITDA Growth Rapid Revenue and EBITDA Growth by Half Year CAD millions Record revenue of over $37 millioni in the second quarter of 2022 Representing an annual run rate of $150 million Adjusted EBITDAii for Q2 increased 90% YoY to $9 million Net income of $6 million for the Q2 of 2022 compared to $2 million in Q2 of 2021 Tenth consecutive quarter of profitable growth Eighth consecutive quarter of positive cash flow from operations $96 million cash on hand Revenue growth expect

  • GlobeNewswire

    InterCure to Release its Q2 2022 Results and Hold a Conference Call

    Conference call scheduled for Tuesday, August 16, 2022, at 8:30am ETNEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the second quarter of 2022 after market close on Monday, August 15, 2022. InterCure executives will host a live conference call and audio webcast to discuss these results on Tuesday, August 1

Advertisement
Advertisement